The weekly litigation news digest is live. Subscribe now

IP Verse

Compositions For The Treatment Of Gastrointestinal Inflammation - EP3354276

The patent EP3354276 was granted to Meritage Pharma on Jan 1, 2020. The application was filed on Nov 12, 2008 under application number EP17210162A. The patent is currently recorded with a legal status of "Revoked".

EP3354276

MERITAGE PHARMA
Application Number
EP17210162A
Filing Date
Nov 12, 2008
Status
Revoked
Apr 15, 2022
Publication Date
Jan 1, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
AECHTEROct 1, 2020TER MEER STEINMEISTER & PARTNERADMISSIBLE
DR FALK PHARMASep 23, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS4900552
DESCRIPTIONUS5814330
DESCRIPTIONUS6306789
DESCRIPTIONUS6348502
DESCRIPTIONUS6509028
DESCRIPTIONUS6562363
DESCRIPTIONUS6638521
OPPOSITIONFR2884422
OPPOSITIONUS2004228919
OPPOSITIONUS2007111978
OPPOSITIONUS3539365
OPPOSITIONWO2009064819
OPPOSITIONWO9609829
SEARCHUS2007111978

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents